As the FDA prepares to implement its long-anticipated alignment with ISO 13485 through the Quality Management System Regulation (QMSR), US medical device manufacturers are facing a classic moment: “is this a challenge or an opportunity?”
Loading...
Bridging the Gap Between Training and Audit Readiness: A Smarter Approach to QMSR Compliance
Loading...
I have been explaining this regulatory shift as being more than compliance. It is about the US market maturing toward a global framework that, if harmonized, will enhance quality, safety, and market access.
But preparing for change means more than just knowing the rules. It’s worth the evolution though. Organizations that integrate training into their broader audit-readiness plans will be better positioned to respond with agility and confidence.
Global Harmonization Is No Longer Theoretical
Behind the QMSR is a growing movement toward international regulatory convergence, championed by groups like the International Medical Device Regulators Forum (IMDRF). As the IMDRF states, its mission is to “strategically accelerate international medical device regulatory convergence to promote an efficient and effective regulatory model… while protecting and maximizing public health and safety.”
The FDA’s QMSR is a clear step in this direction. By replacing 21 CFR 820 with requirements aligned to ISO 13485:2016, the US market is signaling its commitment to consistent global standards—a move that not only reduces duplication for global manufacturers but reinforces the role of quality systems as a foundation for safety and innovation.
Loading...
Will ISO 13485 Remain the Global Benchmark?
An ISO 13485 certification is already the gold standard for quality management systems in the medical device sector. The standard:
- Enhances risk management across the product lifecycle
- Improves operational efficiency through structured processes
- Ensures regulatory compliance critical to market access
- Reinforces stakeholder trust through consistent quality outcomes
Transitioning to the model means organizations must not only align on paper—but also in practice. That’s where informed training becomes essential.
Awareness to Action: Targeted Training
Many organizations begin preparing for QMSR by mapping gaps in their documentation or updating procedures. These are necessary steps, but they don’t address the underlying behaviors, understanding, and cross-functional alignment that audits require.
Training acts as a bridge between intention and execution. When done effectively, it:
- Builds shared understanding across regulatory, quality, and operational teams
- Clarifies expectations under ISO 13485 for those familiar only with legacy FDA regulations
- Encourages early identification of potential weaknesses before an external audit
Companies simply preparing to pass a future audit are missing a trick. They could be taking advantage of this as an opportunity to build competence that sustains improvement.
Loading...
Align Your Training with Audit Strategy
I’ve been in the world of medical device regulation for decades and can tell you: audits are not mere checkpoints. They are opportunities to reflect on the effectiveness of your systems, to gain external perspective, and to validate that your organization can meet both internal goals and regulatory demands.
The Regulatory Affairs Professionals Society (RAPS) highlights that the Quality System Regulation governs not only manufacturing but also labeling, post market surveillance, and more. Understanding how QMSR alters this landscape will be fundamental to being audit ready.
That’s why forward-looking organizations are treating QMSR training not as a one-off event, but as a strategic component of audit preparation, ensuring that what’s learned in training becomes embedded in daily practice.
Course Information: QMSR Awareness Training
To support medical device manufacturers in preparing for this shift, DQS Academy is offering a half-day instructor-led course designed to demystify the QMSR and its alignment with ISO 13485.
QMSR Awareness Training: Transition to FDA aligned with ISO 13485
Format: Instructor-Led Training (ILT)
Duration: Half day (approx. 4 hours)
Who is this for: U.S.-based medical device manufacturers, regulatory affairs, and quality assurance professionals unfamiliar with QMSR or ISO 13485.
Curious?
Send us your details to get more information on the QMSR Awareness Training
Loading...
Learning Objectives:
- Grasp the scope and purpose of the FDA’s QMSR update
- Compare the previous QSR (21 CFR 820) with ISO 13485:2016
- Identify FDA-specific compliance expectations under QMSR
- Describe the implications for manufacturers regarding inspections and records
- Outline strategic steps for QMSR transition before February 2, 2026
- Examine auditor perspectives on key areas of QMSR inspection focus
For manufacturers navigating the transition, early alignment will save you time and headaches. Explore our QMSR course or write to us at DQS Academy to prepare your team with the training and guidance needed to make this transition a success.
Author
Yuan Li, PhD
Dr. Yuan Li holds a doctorate in Mechanical Engineering and has published 13 studies on spinal pathologies and implant innovation. He built his career in Regulatory Affairs, guiding 510(k) and CE certifications across the U.S., EU, and APAC regions. Since joining the notified body sector in 2015, he has advanced from orthopedic product reviewer to management, now overseeing North American operations with a focus on market growth and compliance.
Loading...
